Critical Outcome Technologies Inc. (COTI) is helping the pharmaceutical industry
get novel treatments to market faster.
At COTI’s core is a proprietary technology called CHEMSAS®
that rapidly accelerates drug discovery. COTI is able to discover, profile, optimize,
synthesize and validate novel compounds in 12-15 months. The current industry approach
can take up to 60 months.
Our products are targeted libraries of novel, optimized lead compounds for the treatment
of human diseases for which current therapy is either lacking or ineffective. Learn
more about our pipeline.
Visit our partnering page if you are interested in
augmenting your existing pipeline or developing a pipeline in areas of interest
and reducing the cost of drug discovery.